Annis Gardner Whiting Capital Advisors, LLC Repligen Corp Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $355 Billion
- Q3 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 1,240 shares of RGEN stock, worth $182,218. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,240
Previous 1,298
4.47%
Holding current value
$182,218
Previous $164 Million
12.78%
% of portfolio
0.05%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.11 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$939 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$741 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$239 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$209 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.15B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....